BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25950823)

  • 1. Somatic V600E BRAF Mutation in Linear and Sporadic Syringocystadenoma Papilliferum.
    Levinsohn JL; Sugarman JL; Bilguvar K; McNiff JM; Choate KA; The Yale Center For Mendelian Genomics
    J Invest Dermatol; 2015 Oct; 135(10):2536-2538. PubMed ID: 25950823
    [No Abstract]   [Full Text] [Related]  

  • 2. Syringocystadenoma papilliferum in a patient with focal dermal hypoplasia due to a novel PORCN mutation.
    Schaffer JV; Cantatore-Francis JL; Shin HT; Rosenman KS
    Arch Dermatol; 2009 Feb; 145(2):218-9. PubMed ID: 19221286
    [No Abstract]   [Full Text] [Related]  

  • 3. Syringocystadenoma papilliferum: an unusual presentation.
    Ghosh SK; Bandyopadhyay D; Chatterjee G; Bar C
    Pediatr Dermatol; 2009; 26(6):758-9. PubMed ID: 20199464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of syringocystadenoma papilliferum of eyelid with literature review.
    Behera M; Chatterjee S
    Indian J Ophthalmol; 2015 Jun; 63(6):550-1. PubMed ID: 26265653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syringocystadenoma papilliferum in an unusual location.
    Nascimento BA; Carneiro CM; Carvalho AH; Bittencourt Mde J; Drago MG; Freitas LK
    An Bras Dermatol; 2015; 90(6):900-2. PubMed ID: 26734876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear syringocystadenoma papilliferum: an uncommon event with a favorable prognosis.
    Martorell-Calatayud A; Sanz-Motilva V; Garcia-Sales MA; Calatayud-Blas A
    Dermatol Online J; 2011 Aug; 17(8):5. PubMed ID: 21906485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syringocystadenoma papilliferum arising on the scrotum.
    Dufrechou L; Acosta A; Beltramo P; Pomies V; Caruso R; Salmenton GM; Alvarez M
    Pediatr Dermatol; 2013; 30(3):e12-3. PubMed ID: 22612442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear syringocystadenoma papilliferum: an unusual location.
    Pahwa P; Kaushal S; Gupta S; Khaitan BK; Sharma VK; Sethuraman G
    Pediatr Dermatol; 2011; 28(1):61-2. PubMed ID: 21276059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
    Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
    An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grouped apocrine gland component associated with sporadic syringocystadenoma papilliferum: A case report and BRAFV600E mutation analysis of the two components.
    Mitsui Y; Ogawa K; Takeda M; Kuwahara M; Fukumoto T; Asada H
    J Dermatol; 2019 Nov; 46(11):e395-e398. PubMed ID: 31294472
    [No Abstract]   [Full Text] [Related]  

  • 11. Syringocystadenoma papilliferum: an unusual cutaneous lesion in a pediatric patient.
    Townsend TC; Bowen AR; Nobuhara KK
    J Pediatr; 2004 Jul; 145(1):131-3. PubMed ID: 15238924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of 3 histopathologically documented cases of syringocystadenoma papilliferum involving the eyelid.
    Helmi A; Alaraj AM; Alkatan H
    Can J Ophthalmol; 2011 Jun; 46(3):287-9. PubMed ID: 21784220
    [No Abstract]   [Full Text] [Related]  

  • 13. Giant naevoid syringocystadenoma papilliferum.
    Kaehler KC; Lange-Asschenfeldt B; Proksch E; Hauschild A
    Acta Derm Venereol; 2005; 85(5):453-4. PubMed ID: 16159744
    [No Abstract]   [Full Text] [Related]  

  • 14. Syringocystadenoma papilliferum in an unusual location beyond the head and neck region: a case report and review of literature.
    Yap FB; Lee BR; Baba R
    Dermatol Online J; 2010 Oct; 16(10):4. PubMed ID: 21062598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niemann-Pick disease in association with syringocystadenoma papilliferum.
    Louri N; Darwish A; Alkhalifa K
    Pediatr Dermatol; 2009; 26(6):766-7. PubMed ID: 20199469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nevus comedonicus with hidradenoma papilliferum and syringocystadenoma papilliferum in the female genital area.
    Lee HJ; Chun EY; Kim YC; Lee MG
    Int J Dermatol; 2002 Dec; 41(12):933-6. PubMed ID: 12530358
    [No Abstract]   [Full Text] [Related]  

  • 17. Syringocystadenoma papilliferum.
    Ferringer T
    Cutis; 2011 Dec; 88(6):268, 273-4. PubMed ID: 22372162
    [No Abstract]   [Full Text] [Related]  

  • 18. Somatic BRAF c.1799T>A p.V600E Mosaicism syndrome characterized by a linear syringocystadenoma papilliferum, anaplastic astrocytoma, and ocular abnormalities.
    Watanabe Y; Shido K; Niihori T; Niizuma H; Katata Y; Iizuka C; Oba D; Moriya K; Saito-Nanjo Y; Onuma M; Rikiishi T; Sasahara Y; Watanabe M; Aiba S; Saito R; Sonoda Y; Tominaga T; Aoki Y; Kure S
    Am J Med Genet A; 2016 Jan; 170A(1):189-94. PubMed ID: 26360803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple pigmented trichoblastomas, sebaceous carcinoma and syringocystadenoma papilliferum arising within a nevus sebaceous.
    Song H; Wang Q; Guo Y; Xu XL; Sun JF
    Eur J Dermatol; 2015; 25(3):279-80. PubMed ID: 25906325
    [No Abstract]   [Full Text] [Related]  

  • 20. Linear papules and nodules on the neck. Syringocystadenoma papilliferum (SP).
    Narang T; De D; Dogra S; Saikia UN; Handa S
    Arch Dermatol; 2008 Nov; 144(11):1509-14. PubMed ID: 19015430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.